Calamos Advisors’s Foundation Medicine, Inc. FMI Stock Holding History

Calamos Advisors’s Portfolio FMI Stock Details FMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-24,410	Closed	-$1.17M	–	738
2015 Q1	$1.17M	Buy	24,410 +6,100	+33%	+$277K	0.01%	535
2014 Q4	$407K	Sell	18,310 -4,235	-19%	-$97.7K	﹤0.01%	620
2014 Q3	$427K	Sell	22,545 -9,970	-31%	-$238K	﹤0.01%	600
2014 Q2	$877K	Sell	32,515 -960	-3%	-$24.3K	0.01%	537
2014 Q1	$1.08M	Buy	33,475 +11,439	+52%	+$372K	0.01%	500
2013 Q4	$525K	Buy	+22,036	New	+$616K	﹤0.01%	596

Other funds holding FMI

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CPM

Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return

Calamos Advisors's FMI Position: Q2 2015 in Review

Calamos Advisors sold out of Foundation Medicine, Inc. (FMI) in Q2 2015, closing a stake of 24,410 shares — an estimated $1.17M sold.

Calamos Advisors first reported a position in FMI in Q4 2013 and held it in 6 quarters. The position peaked at $1.17M in Q1 2015. 96 funds tracked by Wall St. Rank hold FMI as of Q2 2015.

Calamos Advisors reported no remaining Foundation Medicine, Inc. position as of Q2 2015 after selling out during the quarter.
Calamos Advisors sold 24,410 Foundation Medicine, Inc. shares in Q2 2015, an estimated $1.17M.
Calamos Advisors first reported a position in Foundation Medicine, Inc. in Q4 2013 and held it in 6 quarters.
Calamos Advisors's Foundation Medicine, Inc. position peaked at $1.17M in Q1 2015.
96 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q2 2015.

Based on Calamos Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.